MORESCO ROSA MARIA

Ninatti, G., Moresco, R., Sollini, M. (2024). Molecular imaging of IDH-mutant gliomas in the new era of IDH inhibitors: preparing for future challenges. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 51(5), 1421-1422 [10.1007/s00259-024-06591-3]. Detail

Cerina, V., Rui, C., DE BERNARDI, E., Moresco, R., Giussani, C., Basso, G., et al. (2024). Preliminary assessment of semiautomated segmentation tool for GBM neurosurgery: a BraTS-Toolkit approach. Intervento presentato a: 19th European Molecular Imaging Meeting - EMIM (European Society of Molecular Imaging - ESMI) - 12-15 March, Porto, Portugal. Detail

Tassan Mazzocco, M., Serra, M., Maspero, M., Coliva, A., Presotto, L., Casu, M., et al. (2024). Positive relation between dopamine neuron degeneration and metabolic connectivity disruption in the MPTP plus probenecid mouse model of Parkinson's disease. EXPERIMENTAL NEUROLOGY, 374(April 2024) [10.1016/j.expneurol.2024.114704]. Detail

Iannone, M., Valtorta, S., Stucchi, S., Altomonte, S., Turolla, E., Vino, E., et al. (2024). Automated radiosynthesis and preclinical evaluation of two new PSMA-617 derivatives radiolabelled via [18F]AlF2+ method. EJNMMI RADIOPHARMACY AND CHEMISTRY, 9(1) [10.1186/s41181-024-00280-0]. Detail

Cerina, V., Crivellaro, C., Morzenti, S., Pozzi, F., Bigiogera, V., Jonghi-Lavarini, L., et al. (2024). A ROI-based quantitative pipeline for 18F-FDG PET metabolism and pCASL perfusion joint analysis: Validation of the 18F-FDG PET line. HELIYON, 10(1) [10.1016/j.heliyon.2023.e23340]. Detail